| 000 | 00613nam a22001697a 4500 | ||
|---|---|---|---|
| 999 |
_c4540 _d4540 |
||
| 008 | 200601b ||||| |||| 00| 0 eng d | ||
| 020 | _a9781138616905 | ||
| 082 |
_a651.7 _bONE |
||
| 100 | _aAlberto Onetti | ||
| 245 |
_aBusiness Modeling For The life Science And biotech Companies And Biotech Companies; _bCreating Value And Competitive Advantage With The MIlestone Bridge |
||
| 260 |
_aLondon And New York _bRoutledge Taylor & Francis Group _c2018 |
||
| 300 |
_ap.xi 193 _bPB |
||
| 365 |
_aRS _b2449/- |
||
| 650 | _aThe Focus OF Biomagen | ||
| 700 | _aAntonella Zucchella | ||
| 942 | _cBK | ||